Novozymes Touts Innova Fit for Ethanol Production (Ind. Report)
Danish enzymes and microbes specialist Novozymes is reporting the launch of Innova Fit -- an advanced non-GM yeast that eliminates ethanol production constraints caused by conventional and basic yeasts. According to the release, Innova Fit:
Powers through high temperature excursions without sacrificing yield -- Higher yields during fermentation temperature excursions, up to 36 degree C/96 degree F, reducing variability and process upsets.
Expands throughput by fermenting high dry solids -- Developed to withstand the rigors of hard running plants, Innova Fit can ferment up to 36 pct dry solids while tolerating high ethanol titers in fermentation.
Increases ethanol yield up to 2 pct -- Operating in a wide variety of fermentation times, Innova Fit excels in fermentations between 55 and 65 hours. As a drop-in solution, Fit converts more sugar to ethanol versus other non-GM yeasts to improve plant profitability.
May reduce need for yeast nutritional supplements: While many yeasts use urea and yeast food to support fermentation, Innova Fit could significantly reduce these costly inputs.
Since 2018, Novozymes has released four yeast solutions as part of its Innova platform.
Yeast and its development are a strategic growth area where Novozymes will continue working with innovation partners in the industry. Its Innova yeast products are the result of a dedicated development partnership with Microbiogen to bring new yeast technology to the market.
Australian-based Microbiogen is an industrial biotechnology company specializing in the development of improved, industrial yeast strains, according to the company website. (Source: Novozymes, PR, GreenCar Congress, 11 Feb. 2020) Contact: Novozymes, Brian Brazeau, VP Bioenergy Commercial, Peder Holk Nielsen, CEO, Michael Burns, Biorefining Business Development North America,(919) 496-6926, www.novozymes.com;
Microbiogen, Geoff Bell, CEO, (02) 9418 3182 firstname.lastname@example.org,
More Low-Carbon Energy News Microbiogen, Novozymes , Yeast, Ethanol,
LanzaTech Carbon Capture Technology Scores Funding (Funding)
Biotechnology specialist LanzaTech, the developer of microbe-based carbon capture and recycling systems that changes carbon-based waste into usable ethanol, is reporting an investment from Novo Holdings, the parent company of Novozymes.
The new Novo Holdings funding will enable LanzaTech to leverage intellectual property held by a subsidiary of Novo Holdings, Novozymes. The result of this partnership should see Lanzatech expanding its production to include other fuels than just ethanol. At its current level of production, LanzaTech estimates it could capture the equivalent of 70,000 vehicles on the world's roads.
LanzaTech aims to develop a circular system where the microbes convert waste products into ethanol, which is then used to fuel the same machinery that produced the waste.
(Source: LanzaRech, Cloud Wedge, 8 Aug., 2019) Contact: LanzaTech, Dr. Jennifer Holmgren, CEO, (630) 439-3050, email@example.com, www.lanzatech.com; Novozymes, Peder Holk Nielsen, President and CEO, Tina Sejersgard Fano, VP Bioenergy, +45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Novozymes, LanzaTech, Carbon Capture,
LanzaTech Announces $72Mn Novo Holdings Investment (Int'l, Funding)
Next generation fuels producer LanzaTech is reporting Novo Holdings will invest $72 million in the company in a Series E financing. The new funds will be used to expand LanzaTech's carbon recycling platform and for commercialization of its Carbon Smart™ products.
Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S.
Lanzatech's gas fermentation technology uses special microbes to recycle residual gases containing carbon monoxide and hydrogen into ethanol. The company's product portfolio includes additional biochemicals besides ethanol, such as chemical specialties and intermediates that can be used as raw materials in other chemical production processes. The technology is also said to be potentially suitable for treating and recycling waste streams in the chemical industry and for municipal waste disposal, according to the company.
(Source: LanzaTech, PR, Biofuels Int'l., 7 Aug., 2019)
Contact: Novo Holdings, +45 3527 6500, www.novoholdings.dk;
LanzaTech, Dr. Jennifer Holmgren, CEO, (630) 439-3050, firstname.lastname@example.org, www.lanzatech.com
More Low-Carbon Energy News LanzaTech, Novo Holdings,
28 Major Corporations Set New Level of Climate Ambition (Int'l. Report)
UN Global Compact,Science Based Targets initiative
In a joint press release from the United Nations Global Compact, the Science Based Targets initiative (SBTi) and the We Mean Business have committed themselves to more ambitious climate targets aligned with limiting global temperature rise to 1.5 degree C above pre-industrial levels and reaching net-zero emissions by no later than 2050.
The joint commitment from the coalition 28 companies with a total market capitalization of $1.3 trillion heeds the most recent report by the Intergovernmental Panel on Climate Change (IPCC) which warned of catastrophic consequences should global warming exceed 1.5 degree C.
Participating companies include: Acciona, AstraZeneca, Banka BioLoo, BT, Dalmia Cement Ltd., Eco-Steel Africa Ltd., Enel, Hewlett Packard Enterprise, Iberdrola, KLP, Levi Strauss & Co., Mahindra Group, Natura &Co, Novozymes, Royal DSM, SAP, Signify, Singtel, Telefonica, Telia, Unilever, Vodafone Group PLC and Zurich Insurance, amongst others, collectively representing over one million employees from 17 sectors and more than 16 countries.
(Source: UN Global Compact, PR, COMTEX, 23 July, 2019) Contact: UN Global Compact, (212) 907-1301, www.unglobalcompact.org; Science Based Targets Initiative, +44 (0) 20 3818 3916,
Sarah.Savage@cdp.net, www.sciencebasedtargets.org; We Mean Business Coalition, Kristen King, (904) 608- 1745
More Low-Carbon Energy News Science Based Targets initiative, UN Global Compact, Carbon Emissions, Climate Change,
Novozymes Touts New Liquefaction Platform (New Prod. & Tech.)
Biofuel technology provider Novozymes reports the launch of
Fortiva, a new alpha-amylase technology that helps customers avoid having to choose between maximizing enzyme performance and operational efficiency. In yeast, Force continues to deliver on the promise to quickly bring innovative, robust, and reliable biological solutions to the market from the Innova yeast platform established last year.
Fortiva is added into liquefaction the same as traditional alpha amylase technologies, but once introduced, it solubilizes more difficult starch than all other amylases on the market
It does this through both the efficient operational use of temperature, as well as the enzyme itself, leading to the highest conversion of starch to dextrins in the market and creating the highest returns on investment. Novozymes sees this proven time and again through an average 20 pct reduction in ethanol plants' residual starch.
Fortiva advances plant efficiency. The fuel ethanol industry initially operated at high liquefaction temperatures (195F/91C) known to better solubilize starch to dextrins, but during this time, enzyme efficiency was limited and required excessive use of chemicals to enable the high operational temperature. Novozymes advancements in enzyme technology (Liquozyme SC) allowed for the removal of unnecessary chemicals (lime) required but required an operational change to more typical operating liquefaction temperatures seen in the fuel ethanol industry today (185F/85C)
Fortiva again allows the ethanol industry to engage very efficient, high temperature liquefactions (195F/91C) while also bringing to market the most advanced alpha amylase to work in this ideal environment, solubilizing more starch without the need for additional chemicals, yielding the highest ethanol production in the market (+1 pct ethanol yield).
Novozyme's Innova Force targets ethanol plants seeking flexibility to achieve operational targets without sacrificing performance. It allows producers to achieve throughput and yield targets without losing ethanol yield to common stressors, such as high temperature and organic acids. Force gives producers the flexibility to push for yield without compromise, and to choose the format that best fits their operation, dry or cream.
Innova Force expresses multiple starch-degrading enzymes for tailored substrate activity, ensuring solubilization and conversion for the lowest residual starch and most optimal fermentation kinetics. Paired with novel glucoamylases, the result is the lowest stress and high performing yeast kinetics and fermentations for exceptional efficiency.
Force is proven to handle tough challenges: Exceptional robustness to high ethanol concentrations, high dry solids -- up to 38 pct temperature excursions up to 104 degree F, and lactic acid excursions up to 0.6 pct. Force expresses multiple enzymes to maximize substrate and starch conversion, and is available in two formats (cream and dry) making it the most advanced dry yeast on the market.
Force eliminates the need for yeast food (100 pct) required by other yeasts, a $300,000 savings (100+MGY plants). Based on plant trials to date, there is potential for significant urea reduction, up to 75 pct depending on individual plant conditions. For every 500lbs of urea reduced, plants can save approximately $130,000 (100+MGY plant). Innova Force eliminates these hidden costs with its flexibility, robustness, and opportunity to run a plant as needed (high throughput or yield):
$500,000 savings in nutrients (urea reduction, and 100 pct elimination of yeast nutrients); $280,000 cost reduction related to poor performing fermentations caused by lack of robustness; 33 pct DS -- plants using advanced yeasts struggle running high dry solids, according to the Novozymes release.
(Source: Novozymes, Trade Release, 10 June, 2019) Contact: Novozymes,
Brian Brazeau, VP, Biofuels Commercial North America, Peder Holk Nielsen, Pres. and CEO, Tina Sejersgard Fano, VP Bioenergy, +45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Novozymes, Ethanol, Yeast,
Attis, Novozymes Collaborate on Biorefinery Technologies (Ind. Report)
Milton, Georgia-based Attis Industries Inc. reports it has inked an agreement with Copenhagen-headquartered Novozymes A/S under which Novozymes will supply enzymes to Attis' planned cellulosic ethanol biorefineries.
Attis has successfully converted the pulp extracted from its patented biomass processing into high yields of sugar using Novozymes' proprietary enzyme cocktails.
Initially, Attis and Novozymes will focus on optimizing the value of the biotechnology utilized in the Attis process. (Source: Attis Industries, Chemical Engineering, Jan., 2019) Contact: Attis Ind., Jeff Cosman, CEO, 678-580-5661, www.attisind.com; Novozymes, Peder Holk Nielsen, President and CEO, Tina Sejersgard Fano, VP Bioenergy, +45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Attis Industries, Novozymes, Biofuel,
Novozymes Reports Growing Bioenergy Segment Sales (Ind. Report)
Further to our August 15th coverage, in its just released Q3, 2018 financial report, Novozymes reports significant growth in demand for enzymes in the conventional biofuel market.
Overall, the company reported 5 pct organic sales growth for Q3, when compared to the same period of 2017. For the first nine months of the year, sales grew by 4 pct organically. Sales in bioenergy were up 14 pct, while agriculture and feed sales grew by 5 pct.
Bioenergy accounted for 19 pct of the company's sales during the first three quarters of 2018. (Source: Novozymes, Various Media, 24 Oct., 2018)Contact: Novozymes, Peder Holk Nielsen, President and CEO, Tina Sejersgard Fano, VP Bioenergy, +45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Novozymes
Novozymes Touts Bioenergy Segment Growth (Ind. Report)
In a just released financial report for the first half of 2018, Novozymes reported 14 pct organic sales growth for its bioenergy segment which accounted for 19 pct of the company's sales during the first half of the year.
The company also noted its newly launched Innova Drive yeast product posted good growth in the second quarter.
Novozymes also reported that sales of enzymes for biomass conversion declined during the first half of 2018 when compared to the same period of last year.
Novozymes also noted that organic sales growth for the bioenergy segment is expected to be driven mainly by new product launches and innovation. (Source: Novozymes, AgraNet, Various Media, 14 Aug., 2018) Contact: Novozymes, Tina Sejersgard Fano, VP Bioenergy,
+45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Novozymes , Enzymes, Bioenergy, Biofuel,
Global Bio-Based Chemicals Sales Market Report 2018 -- Report Available (Ind. Report)
Global Bio-Based Chemicals Sales Market Report 2018
, a new research report from Brooklyn, New York-based QyreseachReports examines the factors that have amplified demand within the global market, market trends and dynamics, as well as
Global Bio-Based Chemicals market manufacturers and players including:
Mitsubishi Chemical Holdings; BASF; PTT Global; Purac; Mitsui & Co.;
Abengoa Bioenergia, S.A; BioAmber Inc., Braskem; Cargill; CORBION Meredian Inc, ;
Metabolix Inc.; Methanex Corporation; Myriant Technologies; NatureWorks;
Novozymes ASS; and
Download report samples HERE.
Browse a complete report HERE.
(Source: QyresearchReports, SBWire, 7 July, 2018)
(518) 621-2074, email@example.com, www.qyresearchreports.com
More Low-Carbon Energy News Biuochemical, Biofuel, Bioenergy,
Novozymes Eying Chinese Enzymes Market Opportunities (Int'l)
The Chinese news agency Xinhua is reporting Danish industrial enzymes specialist Novozymes expects its products to play a major role in the world's third-largest ethanol market, China's ambitious goals for sustainability and development. Novozymes opened its first facility Chine 20 years ago in the Tianjin Economic-Technological Development Area.
Novozymes said ethanol fuel is one of the major opportunities the company sees in China, which plans to push nationwide use of bioethanol-gasoline blends by 2020 to cut emissions and fossil fuel consumption.
With a 48-pct market share in industrial enzymes, Novozymes provides biological solutions for producers of ethanol, bread, detergent and textiles in 130 countries. (Source: Xinhua, Novozymes, 27 May, 2018)
Contact: Novozymes, Sara Dai, Asia Pacific Regional Pres., +45 44 46 00 00, www.novozymes.com
More Low-Carbon Energy News Novozymes, Enzymes, Ethanol,
Global Bio-based Platform Chemicals Market Report -- Report Available (Ind. Report)
Markets Report World,
Markets Report World's Global Bio-based Platform Chemicals Market by Product Type, Top Manufacturer Capacity, Production, Price, Revenue and Market Share, Analysis & Forecast by 2021
is a detailed study of the global bio-based chemicals market dynamics including market growth trends, structure, driving factors, scope, opportunities, challenges, vendor landscape analysis and more.
Global Bio-based Platform Chemicals Market by Top Vendors include: BASF; Cargill; Incorporated; DSM; INEOS; PTT Global Chemical Public Company.
Other prominent vendors include: BioAmber; Braskem; DuPont; GFBiochemicals; LyondellBasell Industries; Mitsubishi Chemical Holdings Corporation; Novozymes; Prinova Group; Qingdao Langyatai (Group); Revolymer; Succinity; Yield10 Bioscience and others.
Global Bio-based Platform Chemicals market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.
Report details and a sample PDF of report are HERE.
Purchase Report HERE. (Source: Market Reports World, 27 May, 2018) Contact: Markets Report World, www.marketreportsworld.com
More Low-Carbon Energy News Biochemical, Biofuel,
Novozymes Intros Yeast for Ethanol Producers (New Prod & Tech)
Danish enzymes and microbes specialist Novozymes reports the unveiling of its new yeast platform for starch-based ethanol production. designed to help ethanol producers ‘get more’ from their raw materials.
The first product in the new yeast platform is Innova Drive, a new yeast strain designed to reduce fermentation time by up to two hours compared to current yeasts, according to Novozymes.
Novozymes claims that during fermentation, Innova Drive produces a higher-performing glucoamylase enzyme. Apparently, this enzyme is twice as effective as glucoamylases produced by other yeast products when it comes to converting sugar into ethanol.
(Source: Noovozymes, Feb., 2018) ,
Contact: Novozymes, Peder Holk Nielsen, CEO, Michael Burns, Biorefining Business Development North America, Peter Halling, VP Biofuel, (919) 496-6926, www.novozymes.com
More Low-Carbon Energy News Novozymes, Yeast, Enzymes, Biofuel,
Showing 1 to 12 of 12.